Home » Cambridge startup Mimicrete gets cash injection for ‘self-healing concrete’

Cambridge startup Mimicrete gets cash injection for ‘self-healing concrete’

by Sion Geschwindt
Cambridge startup Mimicrete gets cash injection for 'self-healing concrete'

Mimicrete, a materials technology startup from the University of Cambridge, has been awarded a £450k Innovate UK Smart Grant and unveiled its first commercial pilot with JP Concrete.

The JP Concrete project is designed to advance the development of the startup’s proprietary biomimetic self-healing concrete.

Vignesh Daas, director at JP Concrete Products, said that the company was delighted to be working with Mimicrete and to be involved in advancing the technology.

Self-healing concrete solutions work to heal concrete cracks as soon as they open up, mitigating further cracking, subsequent structural issues, and the need for repair and early replacement.

The concrete is designed to extend the useful life of new infrastructure while greatly reducing unnecessary costs and carbon emissions.

Dr Lívia Ribeiro De Souza, CTO at Mimicrete and PostDoc Researcher at the University of Cambridge, said: “The support from Innovate UK allows Mimicrete to continue developing the research into the vascular system for self-healing and provides a platform for commercialisation.” 

Leveraging work conducted within the University of Cambridge’s Geotechnical and Environmental Research Group, Mimicrete’s three female founders – along with DeepTech venture builder Cambridge Future Tech – developed a unique approach to disrupt the £800bn global concrete market which accounts for up to 8% of annual carbon emissions.

Arta Selmani, CEO at Mimicrete, said: “With innovation like Mimicrete’s we can help decarbonise the construction industry by using less concrete, cutting ongoing maintenance expenditures, yearly carbon emissions and reducing the overall environmental impact.”

With funding from Innovate UK and backing from US-based Venture Investors such as Vest Coast Capital and Leonas Capital, Mimicrete is well positioned to deliver against its near-term R&D and commercialisation plans.

Dr. Liz Zijing Li, COO at Mimicrete and PhD from University of Cambridge, added: “An InnovateUK grant and US venture investment really helps Mimicrete bring this research to fruition and increase our viability.”

The UK spends £51bn annually on maintaining infrastructure – the most significant use of concrete products.

Image: Dr Lívia Ribeiro De Souza, CTO at Mimicrete and PostDoc Researcher at the University of Cambridge


Read next: Holcim invests in firm that makes concrete carbon negative

Are you a building professional? Sign up for a FREE MEMBERSHIP to upload news stories, post job vacancies, and connect with colleagues on our secure social feed.

Leave a Comment

Related News

Online building news, features and opinions

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More